Literature DB >> 26054921

The role of individual inheritance in tumor progression and metastasis.

Kent Hunter1.   

Abstract

Metastasis, the dissemination and growth of tumor cells at secondary sites, is the primary cause of patient mortality from solid tumors. Metastasis is an extremely complex, inefficient process requiring contributions of not only the tumor cell but also local and distant environmental factors, at both the cellular and molecular level. Variation in the function of any of the steps in the metastatic cascade may therefore have profound implications for the ultimate course of the disease. In addition to the somatic and cellular heterogeneity that can affect cancer outcome, an individual's specific ancestry or genetic background can also significantly influence metastatic progression. These inherited variants not only encoded for metastatic susceptibility but also provided a window to study critical factors that are not easily accessible with current technologies. Furthermore, investigations into inherited metastatic susceptibility enable identification of important molecular and cellular processes that are not subject to mutation and are consequently not detectable by standard cancer genome sequencing strategies. Incorporation of inherited variation into metastasis research therefore provides methods to more comprehensively investigate the etiology of the lethal consequences of tumor progression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26054921      PMCID: PMC6568003          DOI: 10.1007/s00109-015-1299-6

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  46 in total

1.  Breast cancer prognosis is inherited independently of patient, tumor and treatment characteristics.

Authors:  Helena M Verkooijen; Mikael Hartman; Massimo Usel; Simone Benhamou; Isabelle Neyroud-Caspar; Kamila Czene; Georges Vlastos; Pierre O Chappuis; Christine Bouchardy; Elisabetta Rapiti
Journal:  Int J Cancer       Date:  2011-11-17       Impact factor: 7.396

2.  Tumor evolution and intratumor heterogeneity of an oropharyngeal squamous cell carcinoma revealed by whole-genome sequencing.

Authors:  Xinyi Cindy Zhang; Chang Xu; Ryan M Mitchell; Bo Zhang; Derek Zhao; Yao Li; Xin Huang; Wenhong Fan; Hongwei Wang; Luisa Angelica Lerma; Melissa P Upton; Ashley Hay; Eduardo Méndez; Lue Ping Zhao
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

3.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.

Authors:  Héctor Peinado; Maša Alečković; Simon Lavotshkin; Irina Matei; Bruno Costa-Silva; Gema Moreno-Bueno; Marta Hergueta-Redondo; Caitlin Williams; Guillermo García-Santos; Cyrus Ghajar; Ayuko Nitadori-Hoshino; Caitlin Hoffman; Karen Badal; Benjamin A Garcia; Margaret K Callahan; Jianda Yuan; Vilma R Martins; Johan Skog; Rosandra N Kaplan; Mary S Brady; Jedd D Wolchok; Paul B Chapman; Yibin Kang; Jacqueline Bromberg; David Lyden
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

4.  Genome remodelling in a basal-like breast cancer metastasis and xenograft.

Authors:  Li Ding; Matthew J Ellis; Shunqiang Li; David E Larson; Ken Chen; John W Wallis; Christopher C Harris; Michael D McLellan; Robert S Fulton; Lucinda L Fulton; Rachel M Abbott; Jeremy Hoog; David J Dooling; Daniel C Koboldt; Heather Schmidt; Joelle Kalicki; Qunyuan Zhang; Lei Chen; Ling Lin; Michael C Wendl; Joshua F McMichael; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Elizabeth Appelbaum; Katherine Deschryver; Sherri Davies; Therese Guintoli; Li Lin; Robert Crowder; Yu Tao; Jacqueline E Snider; Scott M Smith; Adam F Dukes; Gabriel E Sanderson; Craig S Pohl; Kim D Delehaunty; Catrina C Fronick; Kimberley A Pape; Jerry S Reed; Jody S Robinson; Jennifer S Hodges; William Schierding; Nathan D Dees; Dong Shen; Devin P Locke; Madeline E Wiechert; James M Eldred; Josh B Peck; Benjamin J Oberkfell; Justin T Lolofie; Feiyu Du; Amy E Hawkins; Michelle D O'Laughlin; Kelly E Bernard; Mark Cunningham; Glendoria Elliott; Mark D Mason; Dominic M Thompson; Jennifer L Ivanovich; Paul J Goodfellow; Charles M Perou; George M Weinstock; Rebecca Aft; Mark Watson; Timothy J Ley; Richard K Wilson; Elaine R Mardis
Journal:  Nature       Date:  2010-04-15       Impact factor: 49.962

5.  Bromodomain 4 activation predicts breast cancer survival.

Authors:  Nigel P S Crawford; Jude Alsarraj; Luanne Lukes; Renard C Walker; Jennifer S Officewala; Howard H Yang; Maxwell P Lee; Keiko Ozato; Kent W Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-21       Impact factor: 11.205

6.  The origins of breast cancer prognostic gene expression profiles.

Authors:  Luanne Lukes; Nigel P S Crawford; Renard Walker; Kent W Hunter
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

7.  Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression.

Authors:  T Lifsted; T Le Voyer; M Williams; W Muller; A Klein-Szanto; K H Buetow; K W Hunter
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

8.  Cadm1 is a metastasis susceptibility gene that suppresses metastasis by modifying tumor interaction with the cell-mediated immunity.

Authors:  Farhoud Faraji; Yanli Pang; Renard C Walker; Rosan Nieves Borges; Li Yang; Kent W Hunter
Journal:  PLoS Genet       Date:  2012-09-20       Impact factor: 5.917

9.  Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition.

Authors:  S Turajlic; S J Furney; G Stamp; S Rana; G Ricken; Y Oduko; G Saturno; C Springer; A Hayes; M Gore; J Larkin; R Marais
Journal:  Ann Oncol       Date:  2014-02-06       Impact factor: 32.976

10.  An integrated systems genetics screen reveals the transcriptional structure of inherited predisposition to metastatic disease.

Authors:  Farhoud Faraji; Ying Hu; Gang Wu; Natalie E Goldberger; Renard C Walker; Jinghui Zhang; Kent W Hunter
Journal:  Genome Res       Date:  2013-12-09       Impact factor: 9.043

View more
  5 in total

1.  DHA-mediated regulation of lung cancer cell migration is not directly associated with Gelsolin or Vimentin expression.

Authors:  Mehboob Ali; Kathryn Heyob; Lynette K Rogers
Journal:  Life Sci       Date:  2016-05-05       Impact factor: 5.037

2.  Role of germline variants in the metastasis of breast carcinomas.

Authors:  Ángela Santonja; Aurelio A Moya-García; Nuria Ribelles; Begoña Jiménez-Rodríguez; Bella Pajares; Cristina E Fernández-De Sousa; Elísabeth Pérez-Ruiz; María Del Monte-Millán; Manuel Ruiz-Borrego; Juan de la Haba; Pedro Sánchez-Rovira; Atocha Romero; Anna González-Neira; Ana Lluch; Emilio Alba
Journal:  Oncotarget       Date:  2022-06-30

3.  Alterative Expression and Localization of Profilin 1/VASPpS157 and Cofilin 1/VASPpS239 Regulates Metastatic Growth and Is Modified by DHA Supplementation.

Authors:  Mehboob Ali; Kathryn Heyob; Naduparambil K Jacob; Lynette K Rogers
Journal:  Mol Cancer Ther       Date:  2016-08-05       Impact factor: 6.261

4.  Blood-brain Barrier Remodeling during Brain Metastasis Formation.

Authors:  Jagoda K Wrobel; Michal Toborek
Journal:  Mol Med       Date:  2016-01-13       Impact factor: 6.354

5.  DNA repair genes in astrocytoma tumorigenesis, progression and therapy resistance.

Authors:  Juliana Ferreira de Sousa; Rodolfo Bortolozo Serafim; Laura Marise de Freitas; Carla Raquel Fontana; Valeria Valente
Journal:  Genet Mol Biol       Date:  2019-12-13       Impact factor: 1.771

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.